Emily Pilkington

Emily is a senior vice president of the Global Life Science and Healthcare Team at Silicon Valley Bank in London, UK. She supports innovative biopharma clients across the EMEA region and works with founders, C-suite and investors to provide banking and lending solutions that support client innovation and growth.

Before joining SVB, Emily served as vice president for the Service, Tech and Healthcare Team at DNB ASA, where she was responsible for expanding the healthcare and technology portfolio across Europe. In this role, she helped companies fulfill their growth aspirations by providing financing solutions for M&A, leveraged buyout or corporate purposes, and supporting their global banking, treasury and risk management needs. Emily was also DNB’s ESG (environmental, social and governance) ambassador for corporate clients across Europe.

Emily is passionate about the impact life sciences and the biopharma industry could have on the future of humanity and global health. She believes the pandemic has highlighted biopharma’s ability to innovate at an astonishing rate and hopes to support companies looking to build on this progress and develop solutions that address the global population’s greatest health challenges.

Emily is an associate member of the Association of Corporate Treasurers, AMCT. She credits her AMCT diploma with giving her an in-depth understanding of the treasury, risk management and financing requirements of corporate clients.